IRMD - NASDAQ
IRadimed Corporation
$94.48
+5.1%IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
At a Glance
Live Snapshotirmd
Revenue
Last Annual Value
83.81M
3-Year CAGR
16%
5-Year CAGR
21%
10-Year CAGR
10%
IRadimed Corporation Competitors Analysis of Revenue
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
IRadimed Corporation NASDAQ:IRMD | 83.81M | 8.5% | 14.9% | 9.9% | |
 OPKO Health, Inc. NASDAQ:OPK | 606.88M | -11.1% | -19.3% | -6.8% | |
 MiMedx Group, Inc. NASDAQ:MDXG | 418.63M | 9.2% | 11.6% | 5.5% | |
 Tandem Diabetes Care, Inc. NASDAQ:TNDM | 1.01B | 10.7% | 7.6% | 28.3% | |
 AxoGen, Inc. NASDAQ:AXGN | 225.21M | 12.3% | 12.1% | 18.5% | |
 AdaptHealth Corp. NASDAQ:AHCO | 3.24B | 0.5% | 5.7% | 34.0% | |
 GoodRx Holdings, Inc. NASDAQ:GDRX | 796.85M | 2.0% | 1.3% | 23.1% | |
 Integra LifeSciences Holdings Corporation NASDAQ:IART | 1.64B | 2.0% | 1.2% | 5.1% | |
 Claritev Corporation NYSE:CTEV | 965.41M | 0.1% | -2.9% | N/A |
IRadimed Corporation Fair Value Envelope
Related Guides
Continue your IRMD research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.